 |
市場調查報告書
商品編碼
1529555
發炎藥物市場：按藥物類型、按應用、按給藥途徑、按分銷管道、按地區Anti-inflammatory Drugs Market, By Drug Type, By Application, By Route of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計2024年全球發炎藥物市場規模為1,061億美元，預計2031年將達1,901.1億美元，2024年至2031年複合年成長率為8.7%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 1061億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 8.70% | 2031年價值預測 | 1901.1億美元 |
圖：2024 年按地區分類的發炎藥物市場佔有率(%)
發炎藥物是抑制體內發炎的藥物。它通常用於治療關節疼痛、關節炎以及其他發炎和疼痛病症。發炎藥物的主要類別包括非類固醇消炎劑（NSAID）、皮質類固醇/類固醇、生物製藥和白細胞介素阻斷劑。非類固醇消炎劑，包括Ibuprofen和萘普生，由於其有效性和非處方藥的可用性，是最常用的發炎藥之一。老年人口的增加、關節炎和其他發炎疾病盛行率的上升、人們對發炎疾病的認知不斷提高、新產品的推出等可能會在不久的將來推動發炎藥物市場的成長。
市場動態：
全球發炎藥物市場的成長是由老年人口增加、關節炎和其他發炎疾病盛行率上升、人們對發炎疾病的認知不斷提高以及新產品的核准和上市等因素所推動的。據估計，全球有超過3億人患有類風濕性關節炎。隨著人口老化，關節炎和發炎疾病患者的數量預計將顯著增加。這可能會增加對治療這些疾病的發炎藥物的需求。然而，藥物副作用、重磅藥物專利到期以及膳食食品等替代品的開拓等因素可能會阻礙市場成長。新興國家可能為國際參與者擴大業務提供有利可圖的機會。創新製劑技術的研發以及功效和安全性更高的生物製藥的開發也可能提供新的機會。
本研究的主要特點
- 本報告對全球發炎藥市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。正在做。
- 它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
- 根據公司亮點、產品系列、主要亮點、業績和策略等參數，了解全球發炎藥物市場的主要企業概況。
- 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球發炎藥市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於分析全球發炎藥物市場的各種策略矩陣，將有助於相關人員做出決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球發炎藥物市場：冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球發炎藥市場：按藥物類型，2019-2031，（十億美元）
- 非類固醇消炎劑（NSAlD）
- 免疫選擇性發炎衍生物（ImSAID）
- 發炎生物製藥
- 皮質類固醇
第6章 全球發炎藥物市場：依應用分類，2019-2031 年（十億美元）
- 關節炎
- 慢性阻塞性肺病（COPD）
- 多發性硬化症
- 發炎性腸道疾病（IBD）
- 痛風
- 其他
第7章 全球發炎藥物市場：依給藥途徑，2019-2031 年（十億美元）
- 口服
- 局部的
- 注射
- 吸入
第8章 全球發炎藥市場：依通路分類，2019-2031 年（十億美元）
- 醫院藥房
- 零售藥房
- 網路藥房
第9章 全球發炎藥物市場：按地區分類，2019-2031 年（十億美元）
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
第10章競爭格局
- 公司簡介
- Pfizer, Inc.
- Johnson &Johnson
- Merck &Co., Inc.
- GlaxoSmithKline plc
- Novartis AG
- Eli Lilly and Company
- Sanofi
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca PLC
- Roche Holding AG
- Bristol Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Gilead Sciences, Inc.
- Horizon Therapeutics plc
第11章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI4327
Global Anti-inflammatory drugs market is estimated to be valued at USD 106.10 Bn in 2024 and is expected to reach USD 190.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 106.10 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.70% | 2031 Value Projection: | US$ 190.11 Bn |
Figure. Anti-inflammatory Drugs Market Share (%), By Region 2024
Anti-inflammatory drugs are medications that reduce inflammation in the body. These are commonly used to treat joint pain, arthritis, and other conditions associated with inflammation and pain. Some of the major classes of anti-inflammatory drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids/steroids, biologics, and interleukin blockers. NSAIDs including ibuprofen and naproxen are among the most commonly used anti-inflammatory medications due to their effectiveness and OTC availability. Growing geriatric population, rising prevalence of arthritis and other inflammatory diseases, increasing awareness about inflammatory conditions, and new product launches can drive the anti-inflammatory drugs market growth in the near future.
Market Dynamics:
Global anti-inflammatory drugs market growth is driven by factors such as growing geriatric population, rising prevalence of arthritis and other inflammatory diseases, increasing awareness about inflammatory conditions, new product approvals and launches. As per estimates, over 300 million people suffer from rheumatoid arthritis worldwide. The number of arthritis and inflammatory disease cases is projected to increase significantly due to aging population. This can boost demand for anti-inflammatory drugs for treatment of these diseases. However, factors such as adverse side effects of medications, patent expiries of blockbuster drugs, and development of alternatives like nutraceuticals can hamper the market growth. Emerging economies can offer lucrative opportunities for international players to expand their presence. Ongoing research on innovative formulation technologies and development of biologics with improved efficacy and safety profile can also offer new opportunities.
Key features of the study:
- This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Abbott, Zydus Cadila, Sanofi, Merck, Roche, and Bayer
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market
Detailed Segmentation-
- By Drug Type
- Nonsteroidal Anti-inflammatory Drugs (NSAlDs)
- Immune Selective Anti-inflammatory Derivatives (ImSAlDs)
- Anti-inflammatory Biologics
- Corticosteroids
- By Application
- Arthritis
- Chronic Obstructive Pulmonary Disease (COPD)
- Multiple Sclerosis
- Inflammatory Bowel Disease (IBD)
- Gout
- Others
- By Route of Administration
- Oral
- Topical
- Injection
- Inhalation
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Pfizer, Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis AG
- Eli Lilly and Company
- Sanofi
- AbbVie Inc.
- Amgen Inc.
- AstraZenica PLC
- Roche Holding AG
- Bristol Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Gilead Sciences, Inc.
- Horizon Therapeutics plc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Anti-inflammatory Drugs Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Nonsteroidal Anti-inflammatory Drugs (NSAlDs)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Immune Selective Anti-inflammatory Derivatives (ImSAlDs)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Anti-inflammatory Biologics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Anti-inflammatory Drugs Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic Obstructive Pulmonary Disease (COPD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Multiple Sclerosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inflammatory Bowel Disease (IBD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gout
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inhalation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Anti-inflammatory Drugs Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis AG
- Eli Lilly and Company
- Sanofi
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca PLC
- Roche Holding AG
- Bristol Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Gilead Sciences, Inc.
- Horizon Therapeutics plc
- Pfizer, Inc.
11. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
